Quince Therapeutics Files 8K - Other Events >QNCX

Quince Therapeutics Inc. (QNCX) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on October 09, 2026. On October 7, 2026, the Board approved the termination of the Company's Outside Director Compensation Policy, effective as of October 7, 2026. Effective October 10, 2026, the Company relocated its principal executive office from 611 Gateway Boulevard, Suite 273, South San Francisco, CA, to 101 College Street, Suite 210, New Haven, CT 06510. The Company's telephone number at its new principal executive office is 203-208-8994. The full text of this SEC filing can be retrieved at: Any exhibits and associated documents for this SEC filing can be retrieved at: Public companies must file a Form 8-K, or current report, with the SEC generally within four days of any event that could materially affect a company's financial position or the.